CIS
Capital International Sarl Portfolio holdings
AUM
$5.21B
1-Year Return
36.34%
This Quarter Return
-1.36%
1 Year Return
+36.34%
3 Year Return
+147.48%
5 Year Return
+235.53%
10 Year Return
+580.55%
AUM
$2.19B
AUM Growth
-$43.1M
(-1.9%)
Cap. Flow
+$13.8M
Cap. Flow
% of AUM
0.63%
Top 10 Holdings %
Top 10 Hldgs %
27.01%
Holding
234
New
10
Increased
110
Reduced
89
Closed
14
Top Buys
| 1 |
NVIDIA
NVDA
|
$16.6M |
| 2 |
Broadcom
AVGO
|
$4.74M |
| 3 |
Diebold Nixdorf
DBD
|
$4.53M |
| 4 |
Microsoft
MSFT
|
$4.4M |
| 5 |
Ingersoll Rand
IR
|
$4.3M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$6.67M |
| 2 |
ConocoPhillips
COP
|
$5.78M |
| 3 |
Sea Limited
SE
|
$5.45M |
| 4 |
Costco
COST
|
$4.45M |
| 5 |
UnitedHealth
UNH
|
$4.33M |
Sector Composition
| 1 | Technology | 23.85% |
| 2 | Healthcare | 17.73% |
| 3 | Consumer Discretionary | 13.62% |
| 4 | Financials | 10.68% |
| 5 | Industrials | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Amazon
AMZN
$2.48T
| $5.76M | 0.26% |
45,343
+12,478
| +38% | +$1.59M |
|
102
Arista Networks
ANET
$180B
| $5.75M | 0.26% |
124,968
+18,388
| +17% | +$846K |
|
103
Legend Biotech
LEGN
$6.66B
| $5.59M | 0.26% |
83,201
+7,072
| +9% | +$475K |
|
104
Nice
NICE
$8.67B
| $5.49M | 0.25% |
32,318
-4,511
| -12% | -$767K |
|
105
HEICO
HEI
$44.8B
| $5.46M | 0.25% |
33,729
+25,805
| +326% | +$4.18M |
|
106
Freeport-McMoran
FCX
$66.5B
| $5.39M | 0.25% |
144,599
+8,489
| +6% | +$317K |
|
107
Electronic Arts
EA
$42.2B
| $5.37M | 0.25% |
44,635
-4,667
| -9% | -$562K |
|
108
Gerdau
GGB
$6.39B
| $5.21M | 0.24% |
1,311,682
+74,510
| +6% | +$296K |
|
109
Insulet
PODD
$24.5B
| $5.16M | 0.24% |
32,341
-8,118
| -20% | -$1.29M |
|
110
Ametek
AME
$43.3B
| $5.15M | 0.24% |
34,871
-13,229
| -28% | -$1.95M |
|
111
Cloudflare
NET
$74.7B
| $4.96M | 0.23% |
78,721
+5,066
| +7% | +$319K |
|
112
Uber
UBER
$190B
| $4.66M | 0.21% |
101,280
+7,941
| +9% | +$365K |
|
113
TSMC
TSM
$1.26T
| $4.62M | 0.21% |
53,150
-20,485
| -28% | -$1.78M |
|
|
114
Diebold Nixdorf
DBD
$2.19B
| $4.53M | 0.21% |
+239,275
| New | +$4.53M |
|
115
Take-Two Interactive
TTWO
$44.2B
| $4.48M | 0.21% |
31,912
-6,283
| -16% | -$882K |
|
116
Canadian Natural Resources
CNQ
$63.2B
| $4.46M | 0.2% |
137,142
-52,974
| -28% | -$1.72M |
|
117
Marsh & McLennan
MMC
$100B
| $4.39M | 0.2% |
23,063
-8,078
| -26% | -$1.54M |
|
118
AbbVie
ABBV
$375B
| $4.38M | 0.2% |
29,359
-5,240
| -15% | -$781K |
|
119
Gilead Sciences
GILD
$143B
| $4.36M | 0.2% |
58,159
+22,025
| +61% | +$1.65M |
|
120
Coupang
CPNG
$52.7B
| $4.36M | 0.2% |
256,234
+21,293
| +9% | +$362K |
|
|
121
Ingersoll Rand
IR
$32.2B
| $4.3M | 0.2% |
+67,471
| New | +$4.3M |
|
122
KLA
KLAC
$119B
| $4.27M | 0.2% |
9,319
-3,381
| -27% | -$1.55M |
|
123
The Mosaic Company
MOS
$10.3B
| $4.27M | 0.2% |
120,054
+7,307
| +6% | +$260K |
|
124
Boeing
BA
$174B
| $4.24M | 0.19% |
22,101
-1,464
| -6% | -$281K |
|
125
CRISPR Therapeutics
CRSP
$4.99B
| $4.18M | 0.19% |
92,143
+6,708
| +8% | +$304K |
|